1. Home
  2. ABEO vs BRT Comparison

ABEO vs BRT Comparison

Compare ABEO & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • BRT
  • Stock Information
  • Founded
  • ABEO 1974
  • BRT 1972
  • Country
  • ABEO United States
  • BRT United States
  • Employees
  • ABEO N/A
  • BRT N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • BRT Real Estate Investment Trusts
  • Sector
  • ABEO Health Care
  • BRT Real Estate
  • Exchange
  • ABEO Nasdaq
  • BRT Nasdaq
  • Market Cap
  • ABEO 281.0M
  • BRT 281.9M
  • IPO Year
  • ABEO 1980
  • BRT N/A
  • Fundamental
  • Price
  • ABEO $4.36
  • BRT $15.08
  • Analyst Decision
  • ABEO Strong Buy
  • BRT Strong Buy
  • Analyst Count
  • ABEO 5
  • BRT 1
  • Target Price
  • ABEO $18.20
  • BRT $19.50
  • AVG Volume (30 Days)
  • ABEO 1.5M
  • BRT 46.0K
  • Earning Date
  • ABEO 11-13-2025
  • BRT 11-06-2025
  • Dividend Yield
  • ABEO N/A
  • BRT 6.63%
  • EPS Growth
  • ABEO N/A
  • BRT N/A
  • EPS
  • ABEO 0.99
  • BRT N/A
  • Revenue
  • ABEO $400,000.00
  • BRT $98,407,000.00
  • Revenue This Year
  • ABEO N/A
  • BRT N/A
  • Revenue Next Year
  • ABEO $324.71
  • BRT $4.12
  • P/E Ratio
  • ABEO $4.41
  • BRT N/A
  • Revenue Growth
  • ABEO N/A
  • BRT 2.46
  • 52 Week Low
  • ABEO $3.93
  • BRT $14.17
  • 52 Week High
  • ABEO $7.54
  • BRT $20.22
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 24.72
  • BRT 50.85
  • Support Level
  • ABEO $5.29
  • BRT $14.41
  • Resistance Level
  • ABEO $5.41
  • BRT $14.90
  • Average True Range (ATR)
  • ABEO 0.24
  • BRT 0.34
  • MACD
  • ABEO -0.08
  • BRT 0.04
  • Stochastic Oscillator
  • ABEO 3.49
  • BRT 78.02

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About BRT BRT Apartments Corp. (MD)

BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.

Share on Social Networks: